FDA Clearance Tracker · K213164
Avaira Vitality
Last checked: Nov 20, 2026Latest source record: Oct 26, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Oct 26, 2021
Substantially Equivalent
Time to decision
28 days
Received Sep 28, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K213164
- Device name
- Avaira Vitality
- Applicant
- CooperVision, Inc.
- Applicant location
- San Ramon, CA
- Received
- Sep 28, 2021
- Decided
- Oct 26, 2021
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Lenses, Soft Contact, Daily Wear (LPL)
- Device class
- Class II
- Regulation
- 21 CFR 886.5925
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LPL. The earliest in FDA's data is N17951-S002, decided Feb 26, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K213164
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for CooperVision, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K234127 · Decided Jan 25, 2024 · 28 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
K220070 · Decided Feb 4, 2022 · 25 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
K202756 · Decided Oct 20, 2020 · 29 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.